Blood Coagulation Abnormalities in COVID-19 (Corona Virus Disease-19) Patients

Sohag University

Status: Completed

Conditions: Covid19

Treatments: Diagnostic Test: Blood coagulation profile

Study type: Observational

Funder types: Other

Identifiers

NCT04982263

Soh-Med-21-07-34

Details and patient eligibility

About

The role of the coagulation parameters in predicting the severity of COVID-19 disease will be assessed

Full description

In COVID-19 patients the coagulation parameters Prothrombin concentration (PC), Activated Partial Thromboplastin Time (aPTT), D Dimer, Antithrombin III (ATIII) and Fibrinogen are measured and correlation with disease severity is to be investigated

Enrollment: 125 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

● Confirmed cases with COVID 19

Exclusion criteria

● Known history of blood coagulopathy disorder

Trial design

125 participants in 2 patient groups

Mild cases

Description:

Patients with confirmed COVID-19 and with mild disease

Treatment:

Diagnostic Test: Blood coagulation profile

Severe cases

Description:

Patients with confirmed COVID-19 and with severe disease

Treatment:

Diagnostic Test: Blood coagulation profile